Physician profile
Michael J Nelson
NPI 1124504006
$2,921.70
in general payments reported to CMS, 2019-2025
18 companies · $1,788 in 2025
The $1,788 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $140 · 2023: $643 · 2024: $350 · 2025: $1,788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,781.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $973.55 | 2025 | Optilight |
| Biotissue Holdings INC. | $312.79 | 2024-2025 | |
| Alcon Vision LLC | $301.75 | 2022-2025 | Total30, Tryptyr, Rocklatan |
| Tarsus Pharmaceuticals, INC. | $224.02 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $164.28 | 2023-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $161.43 | 2023-2024 | Miebo, Vyzulta, Xiidra |
| Sight Sciences, INC. | $143.12 | 2025 | Tearcare System |
| Sun Pharmaceutical Industries INC. | $137.08 | 2022-2025 | Cequa |
| Genentech USA, INC. | $109.65 | 2023 | Vabysmo |
| Abbvie INC. | $88.72 | 2023-2025 | |
| Glaukos Corporation | $66.31 | 2023 | |
| Dompe US, INC. | $57.35 | 2025 | Oxervate |
| Thea Pharma INC. | $53.74 | 2022-2025 | Iyuzeh |
| Mallinckrodt Hospital Products INC. | $49.66 | 2025 | Acthar |
| Astellas Pharma US INC | $23.96 | 2024 | Izervay |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $23.37 | 2025 | Omidria |
| Rxsight INC | $17.32 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Lkc Technologies, INC. | $13.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.